Effect of levamisole administration on immunogenic and protective capacity of Brucella abortus RB51

Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2018, Vol 8, Issue 5

Abstract

Background: Brucella abortus strain RB51 is a rough strain that was derived after multiple passages of virulent strain 2308. Levamisole, a potent anthelmintic that is widely used in veterinary medicine, is also known as an immune stimulant. Aim and Objectives: Determine the capability of levamisole to enhance the humoral antibody response and cellmediated immunity as well as protective capacity of RB51 vaccine in mice against challenge with virulent Brucella melitensis strain. Materials and Methods: Six groups of 7–8-week-old female Bulb/C mice were used. Group I was vaccinated I/P with 5 × 108 colony-forming units (CFU) of RB51 strain. Group II was vaccinated I/P with 5 × 108 CFU of RB51 strain simultaneously injected (at 0 day) s/cu with 12.5 mg/Kg levamisole. Group III was vaccinated I/P with 5 × 108 CFU of RB51 strain and injected at 7-day postvaccination with 12.5 mg/Kg levamisole. Group IV was vaccinated I/P with 5 × 108 CFU of RB51 strain and injected at the day of vaccination (0 day) and 7-day postvaccination with 12.5 mg/Kg levamisole. Group V was injected with levamisole alone. Group VI was kept as control group. 8-week postvaccination; all vaccinated as well as control animals groups received I/P challenge of 2 ml dose of 2 × 104 CFU/ml of virulent strain of B. melitensis biovar 3. Results: (Groups III and IV) At the day of vaccination (0 day) and 7-day postvaccination showed the highest significant serum antibody titer measured by ELISA all over the experimental period as well as increase in delayed type hypersensitivity (DTH) response 48 h after elicitation by intradermal inoculation of B. abortus soluble antigen compared to vaccinated control group (Group I). While RB51 vaccinated and simultaneously treated with levamisole (Group II) showed mild elevation in antibody titer as well as the lowest significant increase in DTH response compared to vaccinated control group. Bioassay test of challenged mice groups showed significant improvement in the resistance of vaccinated groups treated with levamisole either 7-day postvaccination (Group III) or 0 and 7 days postvaccination (Group IV) which showed 10% bacteriologically positive mice, whereas only 30% of the vaccinated control mice (Group I) and vaccinated simultaneously treated with levamisole (Group II), were bacteriologically positive.

Authors and Affiliations

Ahmed M A Mansour

Keywords

Related Articles

Study of relation between family history of diabetes mellitus and awareness of diabetes mellitus in Pune urban population

Background: Worldwide, diabetes mellitus (DM) is major non-communicable disease. Information of the disease to patients can prevent morbidities of DM and hence will improve quality of life. For the development of type 2...

Comparison of effects of active recovery and deep water running on soccer players’ indices of muscular damage

Background: The process of recovery plays a significant role in sustaining athletic performance and preventing exhaustion among players. Active recovery (AR) is generally accepted as a series of light intrinsic activity...

Effect of 12 weeks of slow breathing exercise practice on anthropometric parameters in healthy volunteers

Background: Regular practice of slow breathing technique shows improvement in the cardiorespiratory functions. The previous studies have reported that it is well known to decrease the effect of stress which, in turn, imp...

 Bioelectric impedance phase angle as a diagnostic and prognostic marker in carcinoma tongue: A hospital-based study

 Background: Malignancies of tongue represent one of the greatest management challenges for the head and neck oncologists because of the adverse effects of treatment on oral and pharyngeal functions. Diagnosis at l...

Dapsone-induced methemoglobinemia in immune thrombocytopenia: A case report

ITP is a bleeding disorder which is not associated by a systemic disease caused by low platelet count or thrombocytes. However, use of dapsone is limited by adverse effects such as methemoglobinemia, reticulocyte increas...

Download PDF file
  • EP ID EP488820
  • DOI 10.5455/njppp.2018.8.1143004122017
  • Views 46
  • Downloads 0

How To Cite

Ahmed M A Mansour (2018). Effect of levamisole administration on immunogenic and protective capacity of Brucella abortus RB51. National Journal of Physiology, Pharmacy and Pharmacology, 8(5), 535-539. https://europub.co.uk/articles/-A-488820